Key result
Two pediatric patients with acute necrotizing encephalopathy associated with RANBP2 mutations, including a novel p.Leu450Phe variant, exhibited variable clinical outcomes following immunomodulatory therapy.
Why the study?
Expanding documented ANE1 case presentations and clinically significant RANBP2 mutations may improve long-term outcomes through more informed therapeutic decision-making.
Case Report (n=2)
No
The identification of the novel p.Leu450Phe variant in the RANBP2 gene expands the documented genetic mutations associated with acute necrotizing encephalopathy.
May prompt RANBP2 testing in recurrent pediatric ANE; leaves optimal prevention strategies open for prospective studies.
Infection-induced acute encephalopathy 3 (IIAE3) is an autosomal dominant disease resulting from a pathogenic variant in the RANBP2 gene. IIAE3 results in the susceptibility to the recurrence of acute necrotizing encephalopathy (ANE1) which presents as bilateral symmetric thalamic, midbrain and/or hindbrain lesions that typically develops within 1-4 days post-acute viral infection, commonly occurring before age 6. 1-6 These case reports highlight a retrospective analysis of clinical data and radiographic studies on 2 ANE1 cases from our institution. The novel p.Leu450Phe variant of the RANBP2 gene was analyzed using in silico algorithms (PolyPhen-2, SIFT, Mutationtaster) which suggests the p.Leu450Phe variant is probably deleterious. 7 An expansion of documented ANE1 case presentations and clinically significant RANBP2 gene mutations has the potential to improve long term outcomes if more informed therapeutic decision making can be achieved.
No takes yet. Share an insight, caveat, or question.
Hartley et al. (2021) conducted a case report in Acute Necrotizing Encephalopathy (n=2). RANBP2 mutation was evaluated. Two pediatric patients with acute necrotizing encephalopathy associated with RANBP2 mutations, including a novel p.Leu450Phe variant, exhibited variable clinical outcomes following immunomodulatory therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: